Press releases

InDex Pharmaceuticals names Jesper Wiklund Chief Executive Officer

Jesper Wiklund has been appointed Chief Executive Officer of InDex Pharmaceuticals AB (InDex) as of September 1st, 2011. He will bring 17 years of international commercial experience in the biotechnology and pharmaceutical industry to InDex. He will succeed Svante Rasmuson, who has lead the company as co-...

Read more

Industrifonden new major shareholder in InDex Pharmaceuticals

Industrifonden invests MSEK 40 and becomes a new shareholder in InDex Pharmaceuticals, which develops Kappaproct - a drug for treatment of severe inflammatory bowel disease. Current shareholders, including SEB Venture Capital, invest an additional MSEK 35. The financing will in large be used to...

Read more